166 related articles for article (PubMed ID: 33927677)
1. Afterdischarges in Myasthenia Gravis.
Yang L; Guo S; Chen X
Front Neurol; 2021; 12():599744. PubMed ID: 33927677
[No Abstract] [Full Text] [Related]
2. Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.
Kim SW; Sunwoo MK; Kim SM; Shin HY; Sunwoo IN
J Clin Neurol; 2017 Jul; 13(3):287-292. PubMed ID: 28516744
[TBL] [Abstract][Full Text] [Related]
3. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
[TBL] [Abstract][Full Text] [Related]
4. Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis With Peripheral Nerve Hyperexcitability: Case Report and Literature Review.
Yang L
Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):57-61. PubMed ID: 33470659
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological profile of the patients with MuSK positive myasthenia gravis.
Nikolic A; Basta I; Stojanovic VR; Stevic Z; Lavrnic D
Neurol Res; 2014 Nov; 36(11):945-9. PubMed ID: 24825477
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of low frequency repetitive nerve stimulation in patients with myasthenia gravis and its correlation with clinical features].
He XT; Wang LJ; Chen JL; Xie CG; Gan R; Yang R
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2443-2447. PubMed ID: 34399557
[No Abstract] [Full Text] [Related]
7. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
Wolfe GI; Oh SJ
Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
[TBL] [Abstract][Full Text] [Related]
9. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
10. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
Vincent A; Leite MI
Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
[TBL] [Abstract][Full Text] [Related]
12. Afterdischarges following M waves in patients with voltage-gated potassium channels antibodies.
Niu J; Guan H; Cui L; Guan Y; Liu M
Clin Neurophysiol Pract; 2017; 2():72-75. PubMed ID: 30214975
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
[TBL] [Abstract][Full Text] [Related]
14. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
15. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
Konishi T
Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
[TBL] [Abstract][Full Text] [Related]
16. Rituximab treatment of myasthenia gravis: A systematic review.
Tandan R; Hehir MK; Waheed W; Howard DB
Muscle Nerve; 2017 Aug; 56(2):185-196. PubMed ID: 28164324
[TBL] [Abstract][Full Text] [Related]
17. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
Huda S; Woodhall MR; Vincent A; Heckmann JM
Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
19. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients.
Padua L; Tonali P; Aprile I; Caliandro P; Bartoccioni E; Evoli A
Eur J Neurol; 2006 Mar; 13(3):273-6. PubMed ID: 16618345
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
Morren J; Li Y
Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
